Cargando…
Generation of GLA-knockout human embryonic stem cell lines to model peripheral neuropathy in Fabry disease
Fabry disease is an X-linked glycolipid storage disorder caused by mutations in the GLA gene which result in a deficiency in the lysosomal enzyme alpha galactosidase A (AGA). As a result, the glycolipid substrate Gb3 accumulates in critical tissues and organs producing a progressive debilitating dis...
Autores principales: | Kaneski, Christine R., Hanover, John A., Schueler Hoffman, Ulrike H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449667/ https://www.ncbi.nlm.nih.gov/pubmed/36092250 http://dx.doi.org/10.1016/j.ymgmr.2022.100914 |
Ejemplares similares
-
Generation of an in vitro model for peripheral neuropathy in Fabry disease using CRISPR-Cas9 in the nociceptive dorsal root ganglion cell line 50B11
por: Kaneski, Christine R., et al.
Publicado: (2022) -
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy
por: Song, Hui-Yung, et al.
Publicado: (2019) -
Using CRISPR/Cas9-Mediated GLA Gene Knockout as an In Vitro Drug Screening Model for Fabry Disease
por: Song, Hui-Yung, et al.
Publicado: (2016) -
Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related GLA-Variant p.A143T
por: Godel, Tim, et al.
Publicado: (2020) -
Fabry disease due to D313Y and novel GLA mutations
por: Koulousios, Konstantinos, et al.
Publicado: (2017)